我是 LongbridgeAI，我可以總結文章信息。道瓊斯的頭條新聞包括特斯拉第二季度銷量激增和一名司機被控過失殺人。谷歌在歐盟的安卓罰款訴訟中敗訴，而 Blue Owl 的投資者請求提取 47 億美元。SAP 計劃削減成本以進行人工智能投資，Quantum Systems 以 80 億美元的估值籌集了 12 億美元。National Beverage 的股票因特別股息上漲，Yara 收購了一家德克薩斯州的氨氣工廠，香奈兒收購了 Charvet。羅氏的肺癌藥物在試驗中顯示出希望
Tesla Sales Jumped in Second Quarter
The electric automaker sells just three new-car models now, with CEO Elon Musk putting the focus on autonomous vehicles and robotics.
----
Google Loses Fight Against EU's $4.7 Billion Android Fine
The penalty is the largest the EU has handed the company in its efforts to curb Google's online dominance.
----
Blue Owl Investors Ask to Withdraw $4.7 Billion From Flagship Funds
Redemption requests declined from the previous quarter but remained elevated.
----
Tesla Driver Charged With Manslaughter After Crashing Into Texas Home, Killing Woman
Investigators say the driver acted to override the car's automated driving assistance system.
----
SAP Seeks to Rein In Costs to Focus on AI Investments
SAP said it would exercise greater discipline when it comes to hiring and travel expenses as it seeks to redeploy workers in roles where they can make better use of AI.
----
German Drone Maker Quantum Systems Raises Funding at $8 Billion Valuation
Quantum Systems said it had raised $1.2 billion at a valuation of roughly $8 billion, bringing in fresh capital to expand drone production and invest in software for autonomous systems powered by artificial intelligence.
----
Starlink Dominates Internet From Space. Can It Disrupt AT&T and Verizon on the Ground?
SpaceX wants its satellite network to eventually serve cellphones in dense urban areas, but capacity and infrastructure hurdles remain.
----
National Beverage Stock Jumps After LaCroix Owner Declares Special Dividend
National Beverage, the maker of LaCroix sparkling water, announced its 13th special dividend in 22 years, sending shares sharply higher despite mixed annual results.
----
Why Medicare Isn't a Game Changer for Weight-Loss Drugmakers
Medicare is now covering weight-loss drugs for some seniors, in a win for patients. For Wall Street, the math is trickier.
----
Norway's Yara to Buy Texas Ammonia Plant For $1.3 Billion
The addition of U.S. production capacity supports the fertilizer producer's strategy of diversifying energy exposure, capturing economies of scale, and lowering fixed costs.
----
Chanel Snaps Up Storied French Shirtmaker Charvet
It is a rare acquisition for the fashion house as it looks to further widen its offer beyond its famed luxury handbags.
----
Consumers Shun Mid-Sized Packs Amid Price Squeeze, Nestle Says
The company is working to keep prices in check, as U.S. consumers fixate on affordability and buyers shift toward bulk or budget pack sizes, passing over middle formats.
----
Brightline Buys Time as Bankruptcy Loan Talks Continue
After extending its interest payment deadline and securing a small financing, Brightline secures two more weeks to negotiate with lenders.
----
KKR and Energy Capital Partners Look to Bet on DCC's Industry Pivot
The private-equity firms aim to gain from the multi-industry conglomerate's recent pivot to focus on its energy businesses, analysts say
----
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
Experimental drug, divarasib, showed meaningful improvements in both patients' overall survival and the time they survived without the disease worsening.
(END) Dow Jones Newswires
July 02, 2026 17:15 ET (21:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.